![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 40, 30826-30832, October 6, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Max-Volmer-Institut für Biophysikalische Chemie und Biochemie, Fachgebiet Biochemie und Molekulare Biologie, Technische Universität Berlin, Franklinstrasse 29, D-10587 Berlin, Germany
Received for publication, March 27, 2000, and in revised form, June 30, 2000
| |
ABSTRACT |
|---|
|
|
|---|
N-Methylcyclopeptides like
cyclosporins and enniatins are synthesized by multifunctional enzymes
representing hybrid systems of peptide synthetases and
S-adenosyl-L-methionine (AdoMet)-dependent N-methyltransferases. The latter constitute a new
family of N-methyltransferases sharing high homology within
procaryotes and eucaryotes. Here we describe the mutational analysis of
the N-methyltransferase domain of enniatin synthetase from
Fusarium scirpi to gain insight into the assembly of the
AdoMet-binding site. The role of four conserved motifs (I,
2085VLEIGTGSGMIL; II/Y, 2105SYVGLDPS; IV,
2152DLVVFNSVVQYFTPPEYL; and V,
2194ATNGHFLAARA) in cofactor binding as measured by
photolabeling was studied. Deletion of the first 21 N-terminal amino
acid residues of the N-methyltransferase domain did not
affect AdoMet binding. Further shortening close to motif I resulted in
loss of binding activity. Truncation of 38 amino acids from the C
terminus and also internal deletions containing motif V led to complete
loss of AdoMet-binding activity. Point mutations converting the
conserved Tyr223 (corresponding to position 2106 in
enniatin synthetase) in motif II/Y (close to motif I) into Val, Ala,
and Ser, respectively, strongly diminished AdoMet binding, whereas
conversion of this residue to Phe restored AdoMet-binding activity to
~70%, indicating that Tyr223 is important for AdoMet
binding and that the aromatic Tyr223 may be crucial for
AdoMet binding in N-methylpeptide synthetases.
N-Methylated peptides like cyclosporins and enniatins
constitute a class of pharmacologically interesting compounds. They are
synthesized by a special class of enzymes representing hybrid systems
of peptide synthetases and integrated N-methyltransferase domains (1).
Like other peptide synthetases, N-methylcyclopeptide
synthetases follow a so-called thiol template mechanism, in which the substrate amino acids are activated as thioesters mediated by enzyme-bound 4'-phosphopantetheine residues (1-3). Enniatin synthetase was the first N-methylcyclopeptide synthetase to
characterized (4). Sequencing of the enniatin synthetase-corresponding
gene (esyn1) from Fusarium scirpi revealed that
the enzyme is one single polypeptide chain of 347 kDa (5). It consists
of the two modules EA and EB containing the two catalytic binding sites
for the substrates D-hydroxyisovaleric acid and the
branched-chain L-amino acid, respectively (5). The 55-kDa
N-methyltransferase portion M of the enzyme is located
within the EB module. N-Methylation takes place after
covalent binding of the amino acid on the surface of the corresponding
peptide synthetase prior to peptide bond formation (4, 6).
S-Adenosyl-L-methionine
(AdoMet)1 serves as the
methyl donor (4, 7). The mechanism of formation of
N-methylated peptides has been elucidated in the case of the cyclodepsipeptides enniatin (8), beauvericin (9), and cyclosporin (10)
and in actinomycin biosynthesis (11).
Biochemical investigations of the N-methyltransferase
function of enniatin synthetase (4) revealed that, similar to other methyltransferases, S-adenosyl-L-homocysteine
(AdoHcy) and sinefungin are potent inhibitors of the
AdoMet-dependent reaction. Sinefungin acted as a
competitive inhibitor with respect to AdoMet, whereas AdoHcy exhibited
an inhibition pattern characteristic for a partial competitive
inhibitor, suggesting a discrete binding site for this inhibitor. Like
other methyltransferases, the N-methyltransferase domain of
enniatin synthetase can be affinity-labeled by UV irradiation in the
presence of AdoMet labeled at the methyl group (4). The photoreaction
was shown to be site-specific, and a binding stoichiometry of one
methyl group/enzyme molecule was observed (4). It could be shown that
AdoHcy diminished photolabeling of enniatin synthetase with
[methyl-14C]AdoMet or
[methyl-3H]AdoMet; but even in the presence of
excess AdoHcy (100 µM), it was not able to totally
prevent the photoreaction, as did sinefungin; in contrast, the
enzyme-bound radioactivity reached a reduced but constant level of 40%
of the uninhibited control (4). This indicates that AdoHcy does not
directly compete with AdoMet, but binds to a discrete inhibitory site.
AdoHcy reduces the affinity of AdoMet for the enzyme, but, even at
infinite high inhibitor concentrations, allows formation of an
enzyme·AdoMet·AdoHcy complex, which still yields product.
Furthermore, neither sinefungin nor AdoHcy affected substrate
activation (adenylation and subsequent thioacylation). Interestingly,
AdoHcy inhibited the formation of the unmethylated depsipeptide formed
in the absence of AdoMet. In contrast, sinefungin exhibited no
influence on the synthesis of demethylenniatin (4). These findings
confirmed the assumption that two different binding sites for the
inhibitors must be present. This was supported by recent experiments on
N-methylation in cyclosporin synthetase. In this case,
AdoHcy acted as a noncompetitive inhibitor with respect to AdoMet,
indicating the presence of two binding sites in the
N-methyltransferase domains of this multienzyme (12).
Amino acid sequence comparison of the N-methyltransferase
domain of enniatin synthetase with methyltransferases from primary metabolism showed no significant sequence similarities except for one
conserved motif (motif I) (2, 5). A conserved phenylalanine in the
glycine-rich motif I was found to be crucial in positioning the adenine
ring of AdoMet to the HhaI DNA methyltransferase (13). However, the corresponding position of enniatin synthetases is occupied
by the first glycine of motif I (position 2089) (5). In the case of In a previous work on enniatin biosynthesis, Pieper et al.
(17) found a photolabeled nonapeptide after UV irradiation of enniatin
synthetase in the presence of radiolabeled AdoMet and subsequent
chymotryptic digestion. This peptide is located C-terminal to motif I
and contains a conserved tyrosine. The included motif was named motif Y
(see Fig. 1) (18). Motif Y shows high similarity to motif II in DNA
methyltransferase nomenclature (14) both in sequence and in location
relative to motif I (therefore, motif Y is now designated motif II/Y).
Previous investigations indicated that deletion of motif I in the
N-methyltransferase portion of enniatin synthetase results
in a loss of the ability to bind AdoMet as measured by photoaffinity
labeling (19). Here we report on a further mutational analysis of the
N-methyltransferase domain of enniatin synthetase to
elucidate the role of motifs I, II/Y, IV, and V in AdoMet binding.
Materials--
Chemicals were of the highest purity commercially
available. [methyl-14C]AdoMet (dilute sulfuric
acid solution (pH 2.5-3.5), 57 Ci/mol), [methyl-3H]AdoMet (dilute 9:1 hydrochloric
acid/ethanol solution (pH 2.0-2.5), 80 Ci/mmol), and
[carboxyl-14C]AdoMet (dilute sulfuric acid
solution (pH 2.5-3.5), 59 Ci/mol) were purchased from Amersham
Pharmacia Biotech (Braunschweig, Germany). All other chemicals used
were purchased from Sigma (Deisenhofen, Germany), Merck (Darmstadt,
Germany), and Fluka (Neu-Ulm, Germany). Whole molecule alkaline
phosphatase-conjugated anti-mouse IgG and 4-nitrophenyl phosphate
were obtained from Sigma.
Polyacrylamide Gel Electrophoresis--
SDS-polyacrylamide gel
electrophoresis was performed as described by Laemmli (20). Gels
contained 12.5% acrylamide. The relative molecular masses of the
enzymes were determined from their mobilities related to those of the
standard proteins (Sigma).
Protein Determination--
Protein concentrations were
determined via the dye binding method of Bradford (21) using bovine
serum albumin as a standard.
Plasmids, Bacterial Strains, and Culture
Conditions--
Escherichia coli strain XL1-Blue (22) was
used as a host for plasmids derived from pBluescript (Stratagene,
Amsterdam, The Netherlands) and pUC8 (23). The strains were grown in
Luria-Bertani broth (1% NaCl, 0.5% yeast extract, and 1%
Bacto-Tryptone) at the specified temperature. Taq DNA
polymerase, nucleotides, and restriction enzymes were purchased from
Life Technologies, Inc. (Karlsruhe, Germany). Plasmid purification kits
were purchased from QIAGEN (Hilden, Germany).
DNA Manipulations--
DNA manipulations and PCR were performed
using standard methods (24). PCR was performed using a Biometra
UNO-Thermoblock. Automated DNA sequencing was performed using the ABI
Prism 373 genetic analyzer at Firma Martin Meixner (Berlin).
Oligonucleotides--
The oligonucleotides were synthesized by
TIB MOLBIOL (Berlin) and metabion (München, Germany).
Oligonucleotide primers for deletion variants were as follows:
primer 1, ATGGATCCTCAAGTTGAGGGCTGGCA; primer 2, GAACTCGACTGCTGACT; primer 3, GTTGGACGACGCTATTC; primer 4, CGGAATTCGGCGATCTCCAGGATGT; and primer 5, CGGAATTCGAAAGTGGTGGAAAGCTG (restriction endonuclease
recognition sequences are indicated in italic type). Oligonucleotide
primers for site-directed mutagenesis were as follows: primer 1A,
CTCAACAGC(G/T)(C/T)CGTTGGTCTTGAT
(introducing Val and Ala), and primer 2A, ATTAACCCTCACTAAAGG;
primer 1B, ATCAAGACCAACG(A/G)(A/C)GCTGTTGAG (introducing Val and Ala) and primer 2B, ATAGGGCGAATTGGGTA; primer 3A,
CTCAACAGCTTCGTTGGTCTTGAT, and primer 3B,
ATCAAGACCAACGAAGCTGTTGAG (introducing Phe); and primer 4A,
CTCAACAGCAGCGTTGGTCTTGAT, and primer 4B,
ATCAAGACCAACGCTGCTGTTGAG (introducing Ser) (bases differing from
the wild-type N-methyltransferase domain are underlined).
Construction of Expression Vectors--
Plasmid pSK1.6BP
containing the N-methyltransferase domain of the enniatin
synthetase gene (esyn1) from F. scirpi (19) was used for constructing the deletion variants and for mutational analysis. Nucleotide 5652 (amino acid 1884) of esyn1
corresponds to position 1 in pSK1.6BP, and nucleotide 7326 (amino acid
2442) corresponds to position 1674 (amino acid 558). The position of the first amino acid of the N-methyltransferase domain of
esyn1 (position 2014) corresponds to position 131 in
pSK1.6BP, and position 2441 of esyn1 corresponds to position
558 in pSK1.6BP (see Fig. 3). We designated plasmid pSK1.6BP as
"wild-type" N-methyltransferase from enniatin
synthetase. Plasmids REP-pSK1.6BP Site-directed Mutagenesis--
Site-directed mutagenesis was
performed using the method of Higuchi (25) with two subsequent
PCRs. Site-directed mutants Tyr223 Expression and Purification of Recombinant
Proteins--
E. coli strain XL1-Blue cells harboring the
expression vectors were grown in Luria-Bertani medium supplemented with
100 µg/ml ampicillin at 37 °C and 250 rpm until A595 = 0.3 (UVICON 930 spectrophotometer) was reached. The cells were induced
with 1 mM isopropyl- Photolabeling of N-Methyltransferases--
10 µg of partially
purified enzyme (in buffer A) and 0.5 µCi of
[methyl-14C]AdoMet in a total volume of 100 µl were irradiated in an ice-cooled polystyrene microtiter plate at a
distance of 2 cm for 60 min with short-wave UV light (254 nm) using a
45-watt mercury lamp (Imax = 0.2 A). The
reaction was stopped by addition of 1 ml of 7% trichloroacetic acid.
Further sample treatment was done as described (4).
Enzyme-linked Immunosorbent Assay--
Polystyrene microtiter
plates were coated with 100 µl of protein (10 µg/ml of buffer A)
overnight at 4 °C. After saturation with 1% bovine serum albumin
for 2 h at room temperature, the wells were incubated for 2 h
at room temperature with appropriate dilutions of the monoclonal
antibody (mAb 28.7 or mAb 28.34) (26) and alkaline
phosphatase-conjugated rabbit anti-mouse IgG. After addition of the
substrate 4-nitrophenyl phosphate (1 mg/ml), the reaction was monitored
by measuring the absorption at 405 nm after 10, 20, and 30 min.
Sequence Analysis--
Computer programs supplied as part of the
PC Gene sequence analysis package (University of Geneva, Geneva),
PSI-BLAST, and GeneDoc (Clustal W) were used for sequence analysis and
comparison. For structure-guided alignments, the web-based 3D-PSSM
method was used (27, 28).
Sequence Analysis of N-Methyltransferase Domains of Peptide
Synthetases
During the last years, an increasing number of genes from
eucaryotic and procaryotic organisms encoding
N-methylpeptide synthetases have been analyzed. Fig.
1 shows a sequence alignment of
N-methyltransferase domains of peptide synthetases.
These are the domains of enniatin synthetase from F. scirpi
(ESYNscir) (5) and F. sambucinum (ESYNsamb) (18) and the seven domains of cyclosporin
synthetase from the fungus Tolypocladium niveum
(CYSYNd2-5, CYSYNd7, CYSYNd8, and
CYSYNd10) (29). Furthermore, the corresponding sequences of
bacterial synthetases are given: microcystin synthetase A from Microcystis sp. (MCYA_mm1) (30),
actinomycin synthetase II from Streptomyces chrysomallus
(ACMC_sm2 and ACMC_sm3)
(31), and pristinamycin synthetase from Streptomyces
pristinaespiralis (SNBDEpri) and Streptomyces
virginiae (SNBDEvir) (32). The
N-methyltransferase domains of the enniatin synthetases of
Fusarium share high similarity (50-60%) with the other
N-methyltransferase domains of eucaryotic origin
(cyclosporin synthetase), but lower similarity (20-25%) with the
procaryotic systems.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
DNA methyltransferases, the phenylalanine in motif I is also
substituted (14). A structure-guided sequence alignment revealed
additional conserved motifs (II, IV, and V) that were not obvious from
simple alignments (for details, see "Results"). This permits
tertiary structure prediction of the N-methyltransferase
domain of enniatin synthetase and other AdoMet-dependent methyltransferases from their amino acid sequences. Both enniatin synthetases and group
DNA methyltransferases contain a conserved Phe in motif V downstream of motif IV. The Phe in motif V of
DNA
methyltransferases makes van der Waals contact with the AdoMet adenine
(15). Kagan and Clarke (16) identified two motifs (II,
(G/P)(T/Q)(Y/F)(D/A)(V/I)(I/F), corresponding to motif IV in DNA
methyltransferase nomenclature; and III, L(K/R)PGGXL)
conserved in the sequences of AdoMet-dependent
methyltransferases methylating small molecules.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
465, REP-pC1.2RP, and
REP-pSK0.9BR were previously cloned (19). To construct the deletion
variants, pSK1.6BP was cleaved with different restriction enzymes as
indicated in Table I, ligated, and
transformed in E. coli XL1-Blue. Some of the deletion
variants were prepared using the PCR method, followed by digestion with
restriction enzymes and ligation to suitable vectors. The integrity of
all constructs was confirmed by sequencing of both DNA strands.
Overview of the construction strategies of the deletion variants
derived from pSK1.6BP (19)
Ala and
Tyr223
Val were constructed from pSK1.6BP as a template
by PCR mutagenesis using primer pairs 1A/2A and 1B/2B. For mutants
containing Tyr223
Phe, we used primer pairs 3A/2A and
3B/2B; and for Tyr223
Ser, primer pairs 4A/2A and 4B/2B
were used. The first two PCRs were carried out with primers each
differing in two base positions from the wild-type
N-methyltransferase domain nucleotide sequence (positions
668 and 669 of pSK1.6BP corresponding to positions 6318 and 6319 of
esyn1) and two homologous primers located in the 5'- and
3'-regions, respectively, of the template pSK1.6BP. The two
PCR-amplified products (0.7 and 1.0 kilobases) were eluted from
a 1% agarose gel (QIAquick gel extraction kit) and used in the second PCR together with primers 2A and 2B. PCR-amplified fragments
were cleaved with PstI and BamHI and cloned into
pBluescript SK+. Cloning of the PCR fragments yielded
plasmids pMVal, pMAla, pMSer, and pMPhe. The plasmids were sequenced to
ensure the correct nucleotide sequence.
-D-thiogalactopyranoside and cultivated for additional 4-6 h. The cells were harvested by
centrifugation and stored at
80 °C. Wild-type and recombinant proteins of the deletion variants and mutants were purified as follows.
All operations were carried out at 4 °C. Frozen cells from 1-1.5
liters of culture broth (4 g) were ground in a mortar with liquid
nitrogen, resuspended in 10 ml of buffer (50 mM Tris-HCl (pH 8.0), 0.3 M KCl, 1 mM EDTA, 4 mM dithiothreitol, 10% glycerol, 2 mM
phenylmethylsulfonyl fluoride, and 1 mM benzamidine), and digested with DNase for 45 min on ice. The homogenate was centrifuged at 12,000 rpm for 25 min (Sorvall SS34 rotor). The resulting pellet was
resuspended in 10 ml of 8 M urea in buffer A (50 mM Tris-HCl (pH 8.0), 1 mM EDTA, and 4 mM dithiothreitol). After centrifugation for 25 min at
12,000 rpm, the supernatant was diluted to 1 mg/ml protein with buffer
A and dialyzed subsequently against 6, 4, and 2 M urea,
followed by a dialysis step against 50 mM KCl in buffer A. Anion-exchange chromatography on DEAE-cellulose followed the dialysis
steps. Fractions of 2 ml were collected by elution with a gradient from
50 to 250 mM NaCl in buffer A.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (115K):
[in a new window]
Fig. 1.
Amino acid sequence alignment of 14 N-methyltransferase domains from peptide synthetases
of procaryotic and eucaryotic origin. The alignment was made using
the Clustal W alignment program in the GeneDoc package. The following
sequences with their GenBankTM/EBI Data Bank accession
numbers were used: ESYNscir, enniatin synthetase from
F. scirpi (amino acids 2014-2447; Z18755) (5);
ESYNsamb, enniatin synthetase from F. sambucinum
(Z48743) (18); CYSYN, cyclosporin synthetase from T. niveum (Z28383) (29); MCYA, microcystin synthetase A
from Microcystis sp. (AB019578) (30);
ACMC, actinomycin synthetase II from S. chrysomallus (AF204401) (31); and SNBDEpri and
SNBDEvir, pristinamycin synthetase from S. pristinaespiralis (Y11548) and from S. virginiae
(Y11547), respectively (32). Identical amino acid residues are shown in
black. More than 80% sequence similarities are shown in
dark gray; >60% sequence similarities are shown in
light gray. Sequences showing local similarities (motifs I,
II/Y, IV, and V) to methyltransferases are boxed, using the
3D-PSSM web-based method (27, 28).
As shown in Fig. 1, the glycine-rich motif I, which is conserved in
most methyltransferases (14, 16), can also be found in peptide
synthetase N-methyltransferase domains (18). Although no
extensive sequence similarities exist among methyltransferases, the
tertiary structures of the AdoMet-binding domains of these methyltransferases are strikingly similar to each other, suggesting that many methyltransferases may have a common structure (14, 15).
Burmester et al. (18) located the sequence GALDA(V/I)F (showing similarity to motif II of Kagan and Clarke (16)) at the C
terminus of the N-methyltransferase domains of peptide
synthetases. However, structure-guided sequence alignments of the
N-methyltransferase domains of peptide synthetases with
methyltransferases revealed possible additional conserved motifs, as
shown in Fig. 2A (14, 15, 33).
Motif II from DNA methyltransferases can also be found in peptide
synthetase N-methyltransferase domains, designated motif
II/Y (18), similar both in sequence and in location relative to
motif I (Figs. 1 and 2, A and B) (13, 34). Motif
II/Y has been discussed to be involved in AdoMet binding (17) and is also highly conserved in all N-methyltransferase domains
shown in Fig. 1. As shown in Fig. 2A, motifs I, II/Y, and IV
are arranged in the same relative order in each type of
methyltransferase. Furthermore, the highly conserved sequence
NSV(V/A)QYFPXXXYL (corresponding to positions 2159-2171 in
enniatin synthetase from F. scirpi) can be found C-terminal
to motif II/Y in all N-methyltransferase domains of peptide
synthetases (Fig. 1). This sequence corresponds to motif IV in DNA
methyltransferase nomenclature (14, 33), which is similar to motif II
of Kagan and Clarke (16). Amino terminus-proximal downstream of motif
IV, the sequence 2194ATNGHFLAARA is found in F. scirpi enniatin synthetase, which shows similarity to motif V of
DNA methyltransferases, e.g. TaqI
methyltransferase (M.TaqI) (14). This motif
contains a phenylalanine that is absolutely conserved in the
N-methyltransferase domains of peptide synthetases (Fig.
1).
|
The methyltransferases differ in the relative linear order of three regions: the AdoMet-binding region, the catalytic region, and the target recognition region (14). In Fig. 2B, the possible arrangement of the conserved motifs of the N-methyltransferase domain of enniatin synthetase, TaqI methyltransferase, and glycine N-methyltransferase (rat) are shown. The latter two show structural similarities to the N-methyltransferase of enniatin synthetase and other N-methyltransferase domains of peptide synthetases. Our results reveal that the N-methyltransferase domain of enniatin synthetase is more closely related to other methyltransferases than was expected.
Mutational Analysis of the N-Methyltransferase Domain of Enniatin Synthetase
Cloning and Expression of Deletion Variants--
We have
previously demonstrated that the N-methyltransferase domain
of enniatin synthetase could be functionally expressed in E. coli (19) and therefore is suitable for mutational analysis. For
further characterization of the N-methyltransferase domain of enniatin synthetase, seven deletion variants were constructed. The
corresponding proteins were expressed, partially purified after
renaturation, and tested for their ability to bind the cofactor [methyl-14C]AdoMet. The results of Haese
et al. (19) provided evidence that motif I is necessary for
AdoMet binding. However, the size of the truncated part of the gene was
rather large, not allowing a more detailed analysis. Therefore, we
completed this study by construction of additional variants to obtain
more knowledge about the role of four motifs in cofactor binding. This
is shown in Fig. 3B. Two
variants (pM2
1-135 and pM3
1-151) were constructed that differed
in the size of the diminished part of the N terminus, both including
the four conserved motifs shown in Fig. 2B. Variants pM4
499-558, pM5
386-558, and pM8
526-558 are deleted at the C terminus, all including motifs I-V. Furthermore, variants
pM6
291-497 (containing a deletion of motifs IV and V) and
pM7
413-475 (including a deletion of 64 amino acids near the C
terminus) were constructed to study the role of this region in AdoMet
binding. All deletion variants were derived from plasmid pSK1.6BP,
containing the N-methyltransferase domain of
esyn1 and designated as wild-type
N-methyltransferase (see "Experimental Procedures").
Site-directed mutagenesis was used to replace Tyr223 in
motif II/Y by Ala, Val, Ser, and Phe, respectively. The positions and
lengths of the deletion variants and the four mutants are shown in Fig.
3 (B and C).
|
Expression of recombinant proteins was carried out in E. coli and yielded insoluble protein in inclusion bodies. Therefore, it was necessary to renature these proteins with a denaturation/renaturation method. Denaturation with 8 M urea, renaturation via dialysis, and subsequent DEAE chromatography yielded partially purified native protein (see "Experimental Procedures").
Control of Refolding by Enniatin Synthetase
N-Methyltransferase-specific Monoclonal Antibodies--
Billich
et al. (26) showed that the enniatin synthetase-directed
monoclonal antibodies mAb 28.7 and mAb 28.34 are able to recognize the
N-methyltransferase domain of enniatin synthetase in its
native state, but not in the denatured form. These antibodies provided
a suitable tool to follow the denature/renature process. Therefore, we
used them to monitor the refolding of the overexpressed proteins in an
enzyme-linked immunosorbent assay. This could be demonstrated in the
case of variant pM2
1-135. The refolded protein gave a signal
(absorption, 0.35) comparable to that of the renatured wild-type
N-methyltransferase (0.42), whereas denatured protein pM2
1-135 gave only a low response (0.07). The other expressed N-methyltransferase variants behaved identically in the
enzyme-linked immunosorbent assay (data not shown).
Photolabeling of Recombinant N-Methyltransferase Variants--
The
cofactor-binding ability of recombinant proteins was measured by
photoincorporation of [methyl-14C]AdoMet.
Under the conditions described (see "Experimental Procedures") a
linear increase in photolabeling was observed up to 20 min, reaching a
plateau of ~0.3 mol of methyl group/mol of wild-type enzyme (data not
shown). Our results are shown in Fig. 3B. As shown, variants
pM2
1-135 and pM3
1-151, both truncated up to 21 amino acid
residues at the N terminus, were still active. pM3
1-151 exhibited
an even higher AdoMet-binding activity than the wild-type N-methyltransferase. In contrast, removal of short stretches
of the C terminus, as in variants pM4
499-558 and pM8
526-558,
resulted in a loss of AdoMet-binding activity. Variants pM6
291-497
and pM7
413-475 were found to be inactive with respect to cofactor binding. Variant pM6
291-497, containing a deletion of motif V, showed no AdoMet-binding activity in the photolabeling test, as expected. But also variant pM7
413-475, in which only a small part
in a less conserved region of the N-methyltransferase
domains of peptide synthetases was deleted, showed no binding activity, indicating that this sequence may be essential for AdoMet binding.
The deletion variant pM3
1-151 (containing the biggest deletion at
the N terminus) and the wild-type N-methyltransferase were analyzed by SDS-polyacrylamide gel electrophoresis after
photolabeling. Subsequent visualization by autoradiography showed
labeled proteins with the expected molecular masses of 45 kDa for the
deletion variant pM3
1-151 and 62 kDa for the wild-type protein
(Fig. 4).
|
To determine whether the conserved tyrosine in motif II/Y is directly
involved in AdoMet binding, four mutants in which the tyrosine was
replaced by alanine, serine, valine, and phenylalanine, respectively, were constructed by site-directed mutagenesis (see Fig.
3C). The resulting proteins were expressed, partially
purified, and tested via photoincorporation. The mutation variants
pMVal, pMAla, and pMSer showed a significant loss of AdoMet-binding
activity. However, the mutation variant pMPhe showed ~70% of the
wild-type N-methyltransferase AdoMet-binding activity.
| |
DISCUSSION |
|---|
|
|
|---|
The integrated N-methyltransferases of peptide synthetases are highly conserved (Fig. 1) (18) and differ from other methyltransferases with respect to substrate recognition and binding. In contrast to other methyltransferases, the substrate is presented by the 4'-phosphopantetheine group of the peptide synthetase; and therefore, the substrate recognition of the amino acid/growing peptide is simplified. The process of initial substrate recognition and binding occurs in the adenylation domain of the peptide synthetase (2).
Structural analysis of the N-methyltransferase domain of enniatin synthetase revealed, besides the previously described motifs of Burmester et al. (18), three additional known conserved motifs (II, IV, and V) that are also found in, for example, TaqI methyltransferase and glycine N-methyltransferase from rat (Fig. 2B). This work describes the mutational analysis of the N-methyltransferase domain of enniatin synthetase from F. scirpi to obtain more insight into the structural arrangement and the role of motifs I, II/Y, IV, and V in cofactor binding. Expression of the N-methyltransferase variants in E. coli, however, yielded insoluble protein. Therefore, a denaturation/renaturation method had to be used to obtain native protein. The question arose why photolabeling of the recombinant wild-type N-methyltransferase yielded only 0.3 mol of methyl group/mol of enzyme, whereas cross-linking of native Esyn led to a maximum incorporation of 1 mol of labeled methyl group/mol of protein. The reason for this might be the structural features of the multidomain character of Esyn playing a role in the regulation of the integrated N-methyltransferase function. Interestingly, all renatured recombinant proteins, irrespective of their capability to bind AdoMet or not, were recognized by the enniatin synthetase-specific monoclonal antibodies mAb 28.7 and mAb 28.34. These antibodies are directed against native enniatin synthetase and recognize discontinuous epitopes of the N-methyltransferase domain (26). The results show that all the variants containing an internal deletion must possess a similar three-dimensional arrangement as the wild-type enzyme.
Binding studies with [methyl-14C]AdoMet showed
that part of the 21 amino acid residues of the N terminus could be
deleted without loss of binding activity (pM3
1-151). Therefore,
this part of the protein can be excluded to participate in the assembly
of the AdoMet-binding pocket. In the case of EcoRII
methyltransferase, deletion of 97 amino acids (two amino acids prior to
motif I) resulted in a decrease in enzyme activity, whereas further
deletions caused a complete loss of activity (34). In a previous study, Haese et al. (19) reported that further deletion of motifs I and II/Y abolished AdoMet-binding activity. This shows that at least
one of the motifs is involved in AdoMet binding. The glycine-rich motif
I is a common element in the sequences of AdoMet-dependent methyltransferases (4, 14, 16). X-ray structure determination of
different methyltransferases revealed a considerable flexibility concerning the location of motif I in the polypeptide chains. In the
case of the TaqI and HhaI DNA methyltransferases,
motif I is located near the N terminus, forming the AdoMet-binding
site, whereas the DNA-binding site is C-terminal (13, 35-37). In
contrast, in the case of the PvuII DNA methyltransferase,
motif I is located closer to the C terminus (38). The AdoMet-binding
site of glycine N-methyltransferase from rat liver is
located near the C terminus, buried in an additional S domain (39),
similar to chemotaxis receptor methyltransferase CheR from
Salmonella typhimurium, where the AdoMet-binding pocket is
formed by the C-terminal domain (40). As shown in the case of catechol
O-methyltransferase, motif II (corresponds to motif IV in
DNA nomenclature) interacts with neither the substrate nor the cofactor
(41). A similar finding was observed in the case of CheR from S. typhimurium. Truncation of a small part of the C terminus (38 amino acids) of the N-methyltransferase domain of enniatin
synthetase and also deletions of internal sequences containing motifs
I, II/Y, IV, and V (REP-pSK1.6BP
465) (19) as well as only motif V
(pM6
291-497), which contains an absolutely conserved Phe (Fig. 1),
yielded inactive protein. The highly conserved Asn in motif IV (Fig. 1)
of the N-methyltransferase domains of peptide synthetases is
also found in methyltransferases such as TaqI and glycine
N-methyltransferase from rat (35, 36, 42). Cheng et
al. (13) have suggested that the side chain of Asn acts as a donor
in a hydrogen bond to the target adenine and therefore allows direct
transfer of the activated methyl group of AdoMet. Interestingly, the
deletion variant pM7
413-476, with an internal deletion at the C
terminus, gave inactive protein, too. From this result, we conclude
that AdoMet binding also depends on structural elements downstream of
motif V. Further work is necessary to study the role of the C-terminal
region in cofactor binding.
There is some evidence that motif II/Y of the
N-methyltransferase domain of esyn1 also plays a
role in cofactor binding (17). This is supported by the fact that motif
II/Y shows high identity to a motif found in all peptide synthetase
N-methyltransferase domains (see Fig. 1). A tyrosine
(Tyr136) has been reported to form an adduct with AdoMet
after photolabeling of rat guanidinoacetate methyltransferase (43).
Tyr136 is located 66 amino acid residues C-terminal to a
conserved sequence (64L(D/E)(V/L/I)GXGXG) that shows
high similarity to motif I. This led us to the assumption that the
tyrosine in motif II/Y is also part of the binding pocket of the
cofactor. To elucidate this assumption, we constructed four point
mutants in which the tyrosine was replaced by Ala, Val, Ser, and Phe,
respectively. Replacement of tyrosine by the amino acids with aliphatic
side chains yielded proteins with strongly reduced binding capacity
(19-28% compared with the wild-type), whereas the Phe mutant restored
~70% of AdoMet-binding activity. Therefore, we conclude that the
tyrosine in motif II/Y is crucial for the ability of the enzyme to
renature properly or for binding AdoMet. It should be noted that the
aromatic ring of the tyrosine might be critical for the
N-methyltransferase AdoMet-binding activity and that the
hydroxyl moiety is dispensable. Work is in progress to express the
whole esyn1 gene and to test the influence of
N-methyltransferase variants on the overall reaction of the multienzyme.
| |
ACKNOWLEDGEMENTS |
|---|
We are indebted to Drs. Ullrich Keller and Florian Schauwecker for valuable discussions.
| |
FOOTNOTES |
|---|
* This work was supported by Deutsche Forschungsgemeinschaft Grant Zo 43/5-3.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Max-Delbrück-Centrum,
Robert-Rössle-Str. 10, 13125 Berlin, Germany.
§ To whom correspondence should be addressed. Tel.: 49-30-31473522; Fax: 49-30-31473522; E-mail: razzo@chem.tu-berlin.de.
Published, JBC Papers in Press, July 7, 2000, DOI 10.1074/jbc.M002614200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: AdoMet, S-adenosyl-L-methionine; AdoHcy, S-adenosyl-L-homocysteine; PCR, polymerase chain reaction; mAb, monoclonal antibody.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Zocher, R., and Keller, U. (1997) Adv. Microb. Physiol. 38, 85-131 |
| 2. | Kleinkauf, H., and von Döhren, H. (1996) Eur. J. Biochem. 236, 335-351 |
| 3. | Marahiel, M. A., Stachelhaus, T., and Mootz, H. D. (1997) Chem. Rev. 97, 2651-2673 |
| 4. | Billich, A., and Zocher, R. (1987) Biochemistry 26, 8417-8423 |
| 5. | Haese, A., Schubert, M., Hermann, M., and Zocher, R. (1993) Mol. Microbiol. 7, 905-914 |
| 6. | Lawen, A., and Zocher, R. (1990) J. Biol. Chem. 265, 11355-11360 |
| 7. | Billich, A., and Zocher, R. (1990) in Biochemistry of Peptide Antibiotics (Kleinkauf, H. , and von Döhren, H., eds) , pp. 57-79, Walter de Gruyter & Co., Berlin |
| 8. | Zocher, R., Keller, U., and Kleinkauf, H. (1983) Biochem. Biophys. Res. Commun. 110, 292-299 |
| 9. | Peeters, H., Zocher, R., Madry, N., Oelrichs, P. B., Kleinkauf, H., and Kraepelin, G. (1983) J. Antibiot. (Tokyo) 36, 1762-1766 |
| 10. | Zocher, R., Nihira, T., Paul, E., Madry, N., Peeters, H., Kleinkauf, H., and Keller, U. (1986) Biochemistry 25, 550-553 |
| 11. | Keller, U. (1987) J. Biol. Chem. 262, 5852-5856 |
| 12. | Glinski, M. (1999) Studies on the Biosynthesis of Cyclosporin A and Enniatin B.Ph.D. thesis , Technische Universität, Berlin |
| 13. | Cheng, X., Kumar, S., Posfai, J., Pfugrath, J. W., and Roberts, R. J. (1993) Cell 74, 299-307 |
| 14. | Malone, T., Blumenthal, R. M., and Cheng, X. (1995) J. Mol. Biol. 253, 618-632 |
| 15. | Schluckebier, G., O'Gara, M., Saenger, W., and Cheng, X. (1995) J. Mol. Biol. 247, 16-20 |
| 16. | Kagan, R. M., and Clarke, S. (1994) Arch. Biochem. Biophys. 310, 417-427 |
| 17. | Pieper, R., Haese, A., Schröder, W., and Zocher, R. (1995) Eur. J. Biochem. 230, 119-126 |
| 18. | Burmester, J., Haese, A., and Zocher, R. (1995) Biochem. Mol. Biol. Int. 37, 201-207 |
| 19. | Haese, A., Pieper, R., von Ostrowski, T., and Zocher, R. (1994) J. Mol. Biol. 243, 116-122 |
| 20. | Laemmli, U. K. (1970) Nature 227, 680-685 |
| 21. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 |
| 22. | Bullock, W. O., Fernandez, J. M., and Short, J. M. (1987) BioTechniques 5, 376-381 |
| 23. | Messing, J., and Vieira, J. (1982) Gene (Amst.) 19, 269-276 |
| 24. | Sambrook, J., Fritsch, E. F., and Maniatis, T. A. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 25. | Higuchi, R. (1991) in PCR Protocols: A Guide to Methods and Applications (Innis, M. A. , Gelfand, D. H. , Sninsky, J. J. , and White, T. J., eds) , pp. 177-183, Academic Press, New York |
| 26. | Billich, A., Zocher, R., Kleinkauf, K., Braun, D. G., Lavanchy, D., and Hochkeppel, H.-K. (1987) Biol. Chem. Hoppe-Seyler 368, 521-529 |
| 27. | Kelley, L. A., MacCallum, R. M., and Sternberg, M. J. E. (2000) J. Mol. Biol. 299, 501-522 |
| 28. | Fischer, D., Barret, C., Bryson, K., Elofsson, A., Godzik, A., Jones, D., Karplus, K. J., Kelley, L. A., MacCallum, R. M., Pawowski, K., Rost, B., Rychlewski, L., and Sternberg, M. J. (1999) Proteins Struct. Funct. Genet. Suppl. 3, 209-217 |
| 29. | Weber, G., Schörgendörfer, K., Schneider-Scherzer, E., and Leitner, E. (1994) Curr. Genet. 26, 120-125 |
| 30. | Nishizawa, T., Asayama, M., Fujii, K., Herada, K., and Shirai, M. (1999) J. Biochem. (Tokyo) 126, 520-529 |
| 31. | Schauwecker, F., Pfennig, F., Grammel, N., and Keller, U. (2000) Chem. Biol. 7, 287-297 |
| 32. | De Crécy-Lagard, V., Saurin, W., Thibaut, D., Gil, P., Naudin, L., Crouzet, J., and Blanc, V. (1997) Antimicrob. Agents Chemother. 41, 1904-1909 |
| 33. | Posfai, J., Bhagwat, A. S., Posfai, G., and Roberts, R. J. (1989) Nucleic Acids Res. 17, 2421-2435 |
| 34. | Friedman, S., Som, S., and Yang, L. (1991) Nucleic Acids Res. 19, 5403-5408 |
| 35. | Labahn, J., Granzin, J., Schluckebier, G., Robinson, D. P., Jack, W. E., Schildkraut, I., and Saenger, W. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 10957-10961 |
| 36. | Schluckebier, G., Kozak, M., Bleimling, N., Weinhold, E., and Saenger, W. (1997) J. Mol. Biol. 265, 56-67 |
| 37. | Klimasauskas, S., Kumar, S., Roberts, R. J., and Cheng, S. (1994) Cell 76, 357-369 |
| 38. | Gong, W., O'Gara, M., Blumenthal, R. M., and Cheng, X. (1997) Nucleic Acids Res. 25, 2702-2715 |
| 39. | Fu, Z., Hu, Y., Konishi, K., Takata, Y., Ogawa, H., Gomi, T., Fujioka, M., and Takusagawa, F. (1996) Biochemistry 35, 11985-11993 |
| 40. | Djordjevic, S., and Stock, A. M. (1997) Structure 5, 545-558 |
| 41. | Vidgren, J., Svensson, L. A., and Liljas, A. (1994) Nature 368, 354-358 |
| 42. | Ogawa, H., Konishi, K., Takata, Y., Nakashima, H., and Fujioka, M. (1987) Eur. J. Biochem. 168, 141-151 |
| 43. | Takata, Y., and Fujioka, M. (1992) Biochemistry 31, 4369-4374 |
This article has been cited by other articles:
![]() |
T. M. Eckstein, S. Chandrasekaran, S. Mahapatra, M. R. McNeil, D. Chatterjee, C. D. Rithner, P. W. Ryan, J. T. Belisle, and J. M. Inamine A Major Cell Wall Lipopeptide of Mycobacterium avium subspecies paratuberculosis J. Biol. Chem., February 24, 2006; 281(8): 5209 - 5215. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Velkov and A. Lawen Mapping and Molecular Modeling of S-Adenosyl-L-methionine Binding Sites in N-Methyltransferase Domains of the Multifunctional Polypeptide Cyclosporin Synthetase J. Biol. Chem., January 3, 2003; 278(2): 1137 - 1148. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |